Earnings Play McKesson
McKesson's 1Q earnings release on Monday before market, here is how to play it.
Share this:
On Monday, before market, McKesson (MCK) is expected to release 1Q EPS of $2.32 compared to $3.31 the prior year on revenue of approximately $54.1B vs. $55.7B last year. The company is a global distributor of wholesale pharmaceutical and medical products, and on July 29th, the company raised its quarterly cash dividend to $0.42 per share, from $0.41 per share.
Technically speaking, on a daily chart, McKesson's stock price appears to be forming a descending channel that began after price last peaked on June 8th. The RSI also appears to be forming a downward channel that began at roughly the same time. The 20-day moving average recently crossed below the 50-day moving average, a bearish signal. McKesson's stock price will likely fall to its $145.50 support level, blow past it and continue declining to the $140.00 level. If price reaches $140.00, it could pick up momentum and reach the lower trend line of the pattern. If price happens to move upward, its potential should be checked by either the upper trend line or the $158.00 resistance level. If price gets above $158.00, we could see a jump to retest the $165.00 level.
Source: GAIN Capital, TradingView
Technically speaking, on a daily chart, McKesson's stock price appears to be forming a descending channel that began after price last peaked on June 8th. The RSI also appears to be forming a downward channel that began at roughly the same time. The 20-day moving average recently crossed below the 50-day moving average, a bearish signal. McKesson's stock price will likely fall to its $145.50 support level, blow past it and continue declining to the $140.00 level. If price reaches $140.00, it could pick up momentum and reach the lower trend line of the pattern. If price happens to move upward, its potential should be checked by either the upper trend line or the $158.00 resistance level. If price gets above $158.00, we could see a jump to retest the $165.00 level.
Source: GAIN Capital, TradingView
On Monday, before market, McKesson (MCK) is expected to release 1Q EPS of $2.32 compared to $3.31 the prior year on revenue of approximately $54.1B vs. $55.7B last year. The company is a global distributor of wholesale pharmaceutical and medical products, and on July 29th, the company raised its quarterly cash dividend to $0.42 per share, from $0.41 per share.
Technically speaking, on a daily chart, McKesson's stock price appears to be forming a descending channel that began after price last peaked on June 8th. The RSI also appears to be forming a downward channel that began at roughly the same time. The 20-day moving average recently crossed below the 50-day moving average, a bearish signal. McKesson's stock price will likely fall to its $145.50 support level, blow past it and continue declining to the $140.00 level. If price reaches $140.00, it could pick up momentum and reach the lower trend line of the pattern. If price happens to move upward, its potential should be checked by either the upper trend line or the $158.00 resistance level. If price gets above $158.00, we could see a jump to retest the $165.00 level.
Source: GAIN Capital, TradingView
Technically speaking, on a daily chart, McKesson's stock price appears to be forming a descending channel that began after price last peaked on June 8th. The RSI also appears to be forming a downward channel that began at roughly the same time. The 20-day moving average recently crossed below the 50-day moving average, a bearish signal. McKesson's stock price will likely fall to its $145.50 support level, blow past it and continue declining to the $140.00 level. If price reaches $140.00, it could pick up momentum and reach the lower trend line of the pattern. If price happens to move upward, its potential should be checked by either the upper trend line or the $158.00 resistance level. If price gets above $158.00, we could see a jump to retest the $165.00 level.
Source: GAIN Capital, TradingView
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
S&P 500, Nasdaq, Dow Forecast: Rising Yields Test Rally Ahead of Nvidia, Fed 8 22 2026
S&P 500, Nasdaq and Dow test key technical levels as momentum fades, raising the risk of a deeper correction heading into a pivotal week.
GBP/USD, Dow Jones Forecast: Key Technical Scenarios to Watch
GBP/USD and the Dow Jones are approaching critical technical levels amid earning optimism, Fed rate hike expectations, US-Iran developments, and persistent geopolitical risks.
The U.S. Dollar Is Rising Again and Nasdaq Is Feeling It
Nasdaq, the U.S. Dollar Index and Federal Reserve expectations are driving market sentiment ahead of a pivotal FOMC meeting. Razan Hilal, StoneX Market Analyst, explains how rising expectations for a hawkish Federal Reserve, persistent U.S.-Iran tensions and key technical levels on the U.S. Dollar Index could influence currencies, equities and precious metals in the weeks ahead.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.